Home walking program for people with an implantable cardioverter defibrillator (ICD)
Clinical Effectiveness of Exercise After an Implantable Cardioverter Defibrillator (ICD)
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-11192781
This project sees if a 12-week home walking program helps people with an implantable cardioverter defibrillator (ICD) increase daily steps and exercise safely.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11192781 on ClinicalTrials.gov |
What this research studies
If I join, I'll be randomly assigned to a 12-week home walking program called E-ICD or to usual care, and the program gives personalized walking prescriptions, monitoring tools, and remote support from cardiac rehab staff. My daily steps will be tracked and the study will collect safety, fitness, and mental health information, plus interviews about how the program works in real life. The study uses proven protocols from earlier pilot and randomized trials and follows the RE-AIM framework to look at reach and implementation. It will enroll 210 patients across three Seattle-area sites and combine quantitative outcomes with qualitative feedback.
Who could benefit from this research
Good fit: Adults living in the greater Seattle area who have an implantable cardioverter defibrillator (ICD), can walk at home, and are willing to be randomized to a 12-week home exercise program or usual care.
Not a fit: People who cannot walk, have unstable cardiac conditions, live outside the study area, or prefer only supervised in-person rehabilitation are unlikely to benefit from participating.
Why it matters
Potential benefit: If successful, the program could help people with ICDs safely increase physical activity, improve fitness and emotional well-being, and make home-based cardiac rehab easier to access.
How similar studies have performed: The team developed E-ICD from prior pilot studies and randomized trials that showed promise, but this larger pragmatic trial will test whether those results hold across a broader ICD population.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DOUGHERTY, CYNTHIA M — UNIVERSITY OF WASHINGTON
- Study coordinator: DOUGHERTY, CYNTHIA M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.